Search Results - "Loyau, Jérémy" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Robust Antibody–Antigen Complexes Prediction Generated by Combining Sequence Analyses, Mutagenesis, In Vitro Evolution, X-ray Crystallography and In Silico Docking

Robust Antibody–Antigen Complexes Prediction Generated by Combining Sequence Analyses, Mutagenesis, In Vitro Evolution, X-ray Crystallography and In Silico Docking

by Loyau, Jérémy, Didelot, Gérard, Malinge, Pauline, Ravn, Ulla, Magistrelli, Giovanni, Depoisier, Jean-François, Pontini, Guillemette, Poitevin, Yves, Kosco-Vilbois, Marie, Fischer, Nicolas, Thore, Stéphane, Rousseau, François
Published in Journal of molecular biology (14.08.2015)

Get full text

Journal Article

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors

by Loyau, Jérémy, Malinge, Pauline, Daubeuf, Bruno, Shang, Limin, Elson, Greg, Kosco-Vilbois, Marie, Fischer, Nicolas, Rousseau, François
Published in mAbs (2014)

Get full text

Journal Article

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody

by Loyau, Jérémy, Malinge, Pauline, Daubeuf, Bruno, Shang, Limin, Elson, Greg, Kosco-Vilbois, Marie, Fischer, Nicolas, Rousseau, François
Published in mAbs (02.11.2014)

Get full text

Journal Article

ISB 2001, a First-in-Class Trispecific BCMA and CD38 T Cell Engager Designed to Overcome Mechanisms of Escape from Treatments for Multiple Myeloma By Targeting Two Antigens

ISB 2001, a First-in-Class Trispecific BCMA and CD38 T Cell Engager Designed to Overcome Mechanisms of Escape from Treatments for Multiple Myeloma By Targeting Two Antigens

by Pihlgren, Maria, Hall, Olivia, Carretero, Laura, Estoppey, Carole, Drake, Adam, Pais, Daniela, Loyau, Jeremy, Berret, Jeremy, Gruber, Isabelle, Suere, Perrine, Schnorhk, Vincent, Nallet, Emilie, Pouleau, Blandine, Chimen, Myriam, Macoin, Julie, Stainnack, Elodie, Monney, Thierry, Delachat, Aurore, Dreyfus, Cyrille, Matthes, Thomas, Konto, Cyril, Dyson, Michael, Blein, Stanislas, Mbow, Lamine, Wood, Rebecca, Srivastava, Ankita, Zhukovsky, Eugene, Perro, Mario
Published in Blood (15.11.2022)

Get full text

Journal Article

$ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of Relapsed Refractory Multiple Myeloma$

ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of Relapsed Refractory Multiple Myeloma

by Stefano, Sammicheli, Grandclement, Camille, Dehilly, Elie, Panagopoulou, Maria, Martini, Evangelia, Castillo, Rosa, Suere, Perrine, Pouleau, Blandine, Estoppey, Carole, Frei, Julia, Loyau, Jeremy, Monney, Thierry, Wood, Rebecca, Croset, Amelie, Rubod, Alain, Gudi, Girish, Udupa, Venkatesha, Gn, Sunitha, Menon, Vinu, Rasmussen, Daniel, Olsen, Jeppe Koch, Giovannini, Roberto, Chakrapani, Aravind, Blein, Stanislas, Doucey, Marie-Agnes, Drake, Adam, Riva, Alessandro, Konto, Cyril, Perro, Mario, Mbow, Lamine
Published in Blood (23.11.2021)

Get full text

Journal Article

Abstract 2970: Overcoming mechanisms of escape from treatments for multiple myeloma with ISB 2001, a potential first-in-class trispecific BCMA and CD38 targeted T cell engager

Abstract 2970: Overcoming mechanisms of escape from treatments for multiple myeloma with ISB 2001, a potential first-in-class trispecific BCMA and CD38 targeted T cell engager

by Pihlgren, Maria, Carretero, Laura, Berret, Jeremy, Hall, Olivia, Estoppey, Carole, Drake, Adam, Pais, Daniela, Macoin, Julie, Chimen, Myriam, Suere, Perrine, Nallet, Emily, Pouleau, Blandine, Stainnack, Elodie, Loyau, Jeremy, Monney, Thierry, Delachat, Aurore, Dreyfus, Cyrille, Blein, Stan, Kaya, Zeynep, Matthes, Thomas, Croasdale-wood, Rebecca, Edwards, James, Edwards, Claire, Mbow, Lamine, Dyson, Michael, Konto, Cyril, Srivastava, Ankita, Zhukovshy, Eugene, Perro, Mario
Published in Cancer research (Chicago, Ill.) (04.04.2023)

Get full text

Journal Article

CD3/BCMA/CD38 Trispecific Antibodies

CD3/BCMA/CD38 Trispecific Antibodies

by MACOIN, Julie, CHIMEN, Myriam, LOYAU, Jérémy, MONNEY, Thierry, DREYFUS, Cyrille, PIHLGREN BOSCH, Maria, CROASDALE-WOOD, Rebecca, PERRO, Mario, SRIVASTAVA, Ankita, DYSON, Michael, CARRETERO IGLESIA, Laura, PAIS, Daniela, ESTOPPEY, Carole, HALL, Olivia, DRAKE, Adam
Year of Publication 11.07.2024

Get full text

Patent

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells

by Carretero-Iglesia, Laura, Hall, Olivia J., Berret, Jérémy, Pais, Daniela, Estoppey, Carole, Chimen, Myriam, Monney, Thierry, Loyau, Jeremy, Dreyfus, Cyrille, Macoin, Julie, Perez, Cynthia, Menon, Vinu, Gruber, Isabelle, Laurendon, Amélie, Caro, Lydia N., Gudi, Girish S., Matsuura, Tomomi, van der Graaf, Piet H., Blein, Stanislas, Mbow, M. Lamine, Croasdale-Wood, Rebecca, Srivastava, Ankita, Dyson, Michael R., Matthes, Thomas, Kaya, Zeynep, Edwards, Claire M., Edwards, James R., Maiga, Sophie, Pellat-Deceunynck, Catherine, Touzeau, Cyrille, Moreau, Philippe, Konto, Cyril, Drake, Adam, Zhukovsky, Eugene A., Perro, Mario, Pihlgren, Maria
Published in Nature cancer (11.09.2024)

Get full text

Journal Article

CD3/BCMA/CD38 Trispecific Antibodies

CD3/BCMA/CD38 Trispecific Antibodies

by MACOIN, Julie, CHIMEN, Myriam, LOYAU, Jérémy, MONNEY, Thierry, DREYFUS, Cyrille, PIHLGREN BOSCH, Maria, CROASDALE-WOOD, Rebecca, PERRO, Mario, SRIVASTAVA, Ankita, DYSON, Michael, CARRETERO IGLESIA, Laura, PAIS, Daniela, ESTOPPEY, Carole, HALL, Olivia, DRAKE, Adam
Year of Publication 25.04.2024

Get full text

Patent

Abstract 2903: ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38+ malignancies

Abstract 2903: ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38+ malignancies

by Sammicheli, Stefano, Grandclement, Camille, Dheilly, Elie, Panagopoulou, Maria, Martini, Evangelia, Suere, Perrine, Pouleau, Blandine, Estoppey, Carole, Frei, Julia, Loyau, Jeremy, Monney, Thierry, Drake, Adam, Rubod, Alain, Doucey, Marie Agnes, Menon, Vinu, Udupa, Venkatesha, GN, Sunitha, Rasmussen, Daniel, Olsen, Jeppe Koch, Gionannini, Roberto, Gudi, Girish, Srivastava, Ankita, Konto, Cyril, Perro, Mario
Published in Cancer research (Chicago, Ill.) (15.06.2022)

Get full text

Journal Article

CD3/BCMA/CD38 TRISPECIFIC ANTIBODIES

CD3/BCMA/CD38 TRISPECIFIC ANTIBODIES

by MACOIN, Julie, CHIMEN, Myriam, LOYAU, Jérémy, MONNEY, Thierry, DREYFUS, Cyrille, PIHLGREN BOSCH, Maria, CROASDALE-WOOD, Rebecca, PERRO, Mario, SRIVASTAVA, Ankita, DYSON, Michael, CARRETERO IGLESIA, Laura, PAIS, Daniela, ESTOPPEY, Carole, HALL, Olivia, DRAKE, Adam
Year of Publication 09.11.2023

Get full text

Patent

ANTI-TLR4 ANTIBODIES AND USES THEREOF

ANTI-TLR4 ANTIBODIES AND USES THEREOF

by FISCHER NICOLAS, KOSCO-VILBOIS MARIE, ROUSSEAU FRANCOIS, LOYAU JÉRÉMY, ELSON GREG
Year of Publication 30.03.2018

Get full text

Patent

ANTI-TLR4-ANTISTOFFER OG ANVENDELSER DERAF

ANTI-TLR4-ANTISTOFFER OG ANVENDELSER DERAF

by FISCHER, Nicolas, LOYAU, Jérémy, KOSCO-VILBOIS, Marie, ELSON, Greg, ROUSSEAU, Francois
Year of Publication 18.12.2017

Get full text

Patent

ANTI-TLR4 ANTIBODIES AND USES THEREOF

ANTI-TLR4 ANTIBODIES AND USES THEREOF

by FISCHER, Nicolas, LOYAU, Jérémy, KOSCO-VILBOIS, Marie, ELSON, Greg, ROUSSEAU, Francois
Year of Publication 01.11.2017

Get full text

Patent

Cloning, reformatting, and small-scale expression of monoclonal antibody isolated from mouse, rat, or hamster hybridoma

Cloning, reformatting, and small-scale expression of monoclonal antibody isolated from mouse, rat, or hamster hybridoma

by Loyau, Jeremy, Rousseau, François
Published in Methods in molecular biology (Clifton, N.J.) (2014)

Get more information

Journal Article

ANTI-TLR4 ANTIBODIES AND USES THEREOF

ANTI-TLR4 ANTIBODIES AND USES THEREOF

by KOSCO-VILBOIS, MARIE, ELSON, GREG, FISCHER, NICOLAS, LOYAU, JÉRÉMY, ROUSSEAU, FRANCOIS
Year of Publication 04.02.2015

Get full text

Patent

COMMON LIGHT CHAIN ANTIBODY LIBRARIES

COMMON LIGHT CHAIN ANTIBODY LIBRARIES

by LA SALA, Gregory, LOYAU, Jeremy, DYSON, Michael
Year of Publication 07.12.2023

Get full text

Patent

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody

by Loyau, Jérémy, Malinge, Pauline, Daubeuf, Bruno, Shang, Limin, Elson, Greg, Kosco-Vilbois, Marie, Fischer, Nicolas, Rousseau, François
Published in mAbs (02.11.2014)

Get full text

Report

Staphylococcus aureus Strains Isolated from Bloodstream Infections Changed Significantly in 2006

Staphylococcus aureus Strains Isolated from Bloodstream Infections Changed Significantly in 2006

by Mee-Marquet, Nathalie van der, Epinette, Christophe, Loyau, Jeremy, Arnault, Laurence, Domelier, Anne-Sophie, Losfelt, Barbara, Girard, Nicole, Quentin, Roland
Published in Journal of Clinical Microbiology (01.03.2007)

Get full text

Journal Article

ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF

ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF

by MACOIN, Julie, LOYAU, Jeremy, MONNEY, Thierry, DOUCEY, Marie-Agnes, CROSET, Amelie, LABANCA, Valentina, MBOW, Lamine
Year of Publication 03.10.2024

Get full text

Patent